Loading clinical trials...
Loading clinical trials...
Investigate the long-term impact of amount and duration of Tailored Lighting Intervention (TLI) obtained from Aims 1 and 2 on sleep, cognition, circadian marker, mood, and behavior in AD/ADRD patients...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Collaborators
NCT07033494 · Early Alzheimer's Disease
NCT07101380 · Mild Cognitive Impairment (MCI)
NCT06121544 · Alzheimer Disease, Mild Cognitive Impairment, and more
NCT06467539 · Alzheimer Disease, Mild Cognitive Impairment
NCT06159673 · Alzheimer's Disease Psychosis
Icahn School of Medicine at Mount Sinai
Menands, New York
Icahn School of Medicine at Mount Sinai
New York, New York
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions